Total daily bile acid excretion was measured in 10 patients with primary hypercholesteremia and in nine patients with combined hypercholesteremia and hypertriglyceridermia by using "GC-labeled cholic acid and 3H-labeled chenodeoxycholic acid. The average bile acid excretion by the patients with primary hypercholesteremia was 282 mg/day; that by the patients with combined hypercholesteremia and hypertriglyceridemia, 1,094 mg/day. These findings suggest a fundamental difference in cholesterol metabolism in these two types of hyperlipidemia.
SUMMARY
Total daily bile acid excretion was measured in 10 patients with primary hypercholesteremia and in nine patients with combined hypercholesteremia and hypertriglyceridermia by using "GC-labeled cholic acid and 3H-labeled chenodeoxycholic acid. The average bile acid excretion by the patients with primary hypercholesteremia was 282 mg/day; that by the patients with combined hypercholesteremia and hypertriglyceridemia, 1,094 mg/day. These findings suggest a fundamental difference in cholesterol metabolism in these two types of hyperlipidemia.
Additional Indexing Words: Hyperlipidemia
Thin layer chromatography FROM a quantitative point of view the mechanisms for cholesterol excretion included oxidation of cholesterol to bile acids and intestinal secretion of cholesterol as neutral fecal steroids. In a steady state of metabolism, bile acid turnover is equal to the rate of bile acid synthesis which represents the rate of oxidation of cholesterol to bile acids. In this paper, the term "cholesterol excretion" represents the sum of the neutral fecal steroids secreted and the bile acids formed by oxidation of cholesterol.
In 1967 it was reported' from this laboratory that large doses of nicotinic acid did not alter daily bile acid excretion in six hypercholesteremic patients. One of these patients excreted 1,160 mg of bile acid daily during the control period while the range of bile acid excretion in the other five patients under the same conditions was 193 to 348 mg/day. This observation suggested that the dynamics of cholesterol excretion might be different in different types of From Cholesterol excretion patients. This report is an extension of this observation. Methods A total of 10 patients with primary hypercholesteremia and nine patients with combined hypercholesteremia and hypertriglyceridemia have been studied. One of the patients in the latter group has been studied twice. All except the last three patients were studied as outpatients, but they were eating a standard diet at the Mayo Clinic Diet Kitchen. The last three patients, one with primary hypercholesteremia and two with combined hypercholesteremia and hypertriglyoeridemia, were studied in a metabolic unit. The diet used contained 200 to 250 mg of cholesterol and 50 g of fat (mainly saturated). At least 80% of the carbohydrate was complex in type. Serum cholesterol and triglyceride levels were measured three times during each study period. The cholesterol levels were determined by a modified ferric chloride method2 which, when compared with the Abel-Levy method, has given identical results in a large series of patients. Serum triglycerides were determined by a modification (to be published) of the method described by Van Handel and Zilversmit. 3 The pool sizes and turnovers of cholic and chenodeoxycholic acids were determined by a double-isotope technic similar to that described by Lindstedt4 and Danielsson and associates.5 For practical purposes, the distribution of bile acids is limited to the liver, biliary system, intestines, and portal vein. Thus, in the absence of biliary obstruction, there is a freely miscible pool undergoing an enterohepatic circulation. Since, in the human, cholic and chenodeoxycholic acids are the only primary bile acids formed directly from oxidation of cholesterol, the sum of their turnovers represents total bile acid excretion.
Each patient was given about 20 ,c of choliccarboxyl-14C acid (specific activity, 5.2 to 37 mc/mmole) and 30 to 40 ,uc of randomly tritiated chenodeoxycholic acid (specific activity, 0.245 mc/mg) orally. The specific activities of cholic and chenodeoxycholic acids were determined in five samples of duodenal contents obtained by repeated intubation over a subsequent 10-day period. Care was taken to remove only a small amount of bile and thus avoid any depletion of the bile acid pool. Also, to avoid the theoretic possibility of stimulating hepatic bile flow and thus altering the mixing of radioactive and stable bile acids, cholecystokinin was not used. The "AClabeled cholic acid was obtained from Tracerlab (Waltham, Mass.). Each lot was checked for 100,000 purity by thin-layer chromatography.* The randomly tritiated chenodeoxycholic acid was prepared by the Wilzbach technic and purified by thin-layer chromatography.* As a further in vivo check of its purity, a dose of this tritiated chenodeoxycholic acid combined with a dose of chenodeoxycholic-carboxyl-14C acid (specific activity, 30.4 mc/mmole; obtained from Tracerlab and checked for purity by thin-layer chromatography) was given to a normal subject; bile samples were obtained by duodenal intubation 24 and 48 hours later; the chenodeoxycholic acid was isolated by thin-layer chromatography, and the ratio of 3H to 14C in the isolated chenodeoxycholic acid was compared to that in the administered dose. The results indicated that less than 10% of the tritium label was lost in vivo.
The specific activities of cholic and chenodeoxycholic acids were determined by use of quantitative thin-layer chromatography followed *Solvent system: isooctane-ethyl acetate-glacial acetic acid (5:5:1, v/v). by spectrophotometric measurement of sulfuric acid chromogens as previously described. 6 7 Instead of an alkaline hydrolysis, an enzymatic hydrolysis as described by Nair and associates8 was used. The scintillating solution contained 0.5 ml of ethanol and 25 ml of toluene-PPO-POPOP* containing 4% Cab-O-Sil. With this scintillating solution, polyethylene vials, and settings for simultaneous 14C and 3H counting, the counting efficiencies averaged 68% for 14C and 27% for 3H. The efficiencies were checked on each sample using the automatic external standard of the Packard Tri-Carb spectrometer.
As described by Lindstedt,4 the logarithms of the specific activities were plotted against time, as shown in figures 1 and 2. Since the excretion of these two bile acids follows first-order kinetics,
in which It = specific activity of the bile acid at time t; Io = specific activity of the bile acid at zero time; t = time in days; and k = elimination constant. The value of Io can be obtained by extrapolation of the curve to the ordinate. By definition, P = D/Io, in which P = pool size in milligrams and D = dose of administered label as DPM. The biologic half-life is described by the formula:
tO'r= (ln, 2)/k, or k= (lne 2)/t12 or, k= 0.693/tJ3. The daily excretion or turnover, T, is described by the equation: T = kP.
Results
The clinical characteristics of the patients are summarized in table 1. Patients 12 and 13 are brothers and have a strong family history of hyperlipemia. Further detailed family studies are in progress. The patient from the previous study1 (patient 6) who had combined hypercholesteremia and hypertriglyceridemia was restudied after an interval of 18 months. At the time of the second study, the severity of the lipid changes had increased markedly, bile acid excretion had increased, and numerous eruptive xanthomata had appeared on the plantar surface of the feet; there had been no change in her diet.
The results of this study are summarized in table 2. Since they were the same, the control data from the previous study on patients' were combined with those in the current study. The conditions of the two studies were the same, except that in the previous study the amount of dietary fat varied between 23 and 59 g, whereas in the current study it was maintained at 50 g. The serum cholesterol levels in the two groups were similar, with the distinction between the two groups being dependent on serum triglyceride levels.
Lipoprotein patterns were obtained in four of the patients with primary hypercholesteremia (method to be published), and all demonstrated an excess of 83-lipoproteins with no more than a faint trace of pre-,8-lipoprotein.
Patterns were obtained on all of the patients with combined hypercholesteremia and hypertriglyceridemia. All had an excess of pre-f3lipoprotein (usually a large excess), and three of them also had moderate to large amounts of chylomicrons as well. Because these patients were on diets restricted in fat when these blood samples were obtained, they could not be accurately placed in the classification described by Fredrickson and associates. 9 A striking difference in total bile acid excretion between these two groups of patients is apparent from table 2. The difference is due to a difference in both cholic acid and chenodeoxycholic acid excretion. It is most striking in the case of cholic acid turnover, for which there is no overlap between the two groups. All of these differences in bile acid excretion are highly significant (P <0.01). Relationship of serum cholesterol level to rate of total bile acid excretion (abscissa). It was reported previously1 that patients who have had cholecystectomy appear to have a small bile acid pool and a shortened biologic half-life of bile acids. This same finding wvas present in the four patients in this study on whom cholecystectomy had been done previously. In both dogs10 and patients, it appears that these two factors compensate for each other, resulting in little alteration in bile acid excretion. Because of this, we have eliminated those patients with a previous cholecystectomy from the data relative to bile acid pools. A difference in the size of the cholic acid pools was noted but was of borderline significance (RP < 0.05). No alteration of the chenodeoxycholic acid pool size was apparent.
No correlation is apparent between the serum cholesterol level and the total bile acid excretion in figure 3 . When the patients with normal serum triglyceride levels are compared with those wvith increased triglyceride levels, a difference in bile acid excretion is readily apparent.
In table 3, the data on the individual patients are listed. Patient 11 was unusual in that no deoxycholic acid was present in any of the bile samples. He had been taking nicotinic acid (6 g/day) and neomycin (250 mg/ day) but had discontinued these medications for 5 weeks prior to the study. If his data were not included in the study, there would be no overlap between the two groups. Others 1113 have noted the absence of deoxycholic acid in the bile of an occasional patient (two such patients had primary hypercholesteremia). Although our patient11 may have had a persistence of a neomycin effect, this seems unlikely. To date we have not encountered any other patients with this finding.
Discussion
Only limited data are available concerning the rates of bile acid excretion in normal subjects. Lindstedt4 measured cholic acid turnover in eight healthy subjects on a "normal" diet and obtained an average excretion of 360 mg/day (range, 260 to 690 mg/day). Danielsson and associates,5 using a double-isotope technic, studied two normal subjects and found the turnover of cholic acid to be 200 and 190, mg/ Circulation, Volume XL, July 1969 18 KOTTKE Limited studies in two normal subjects on the diet used in the present study revealed a cholic acid turnover of 283 mg/day in one and a cholic acid turnover of 263 mg/day and a chenodeoxycholic acid turnover of 188 mg/day (total excretion, 451 mg/day) in the other.
Using a method for the chemical quantitation of fecal bile acid excretion by combined thin-layer and gas-liquid chromatography, Miettinen and co-workers14 found an average excretion of 220 mg/day in 19 normal subjects on a solid-food diet. In support of the present finding, he reported that the average excretion in eight members of a family with primary hypercholesteremia was significantly lower, 154 mg/day. Recently, Grundy and Ahrens,l5 using similar methods in patients on various liquid-formula diets, found fecal bile acid excretion to be 202, 218, 267, 302, 162, 220, 110, and 93 mg/day in eight patients with type II hyperlipoproteinemia and 799 and 431 mg/day in two patients with type V hyperlipoproteinemia (types as described by Fredrickson and associates9 ).
To the author's knowledge, comparison of bile acid excretion in patients with primary hypercholesteremia to that in patients with combined hypercholesteremia and hypertriglyceridemia on the same standard diet has not been reported previously.
The data presented support the concept that primary hypercholesteremia and combined hypercholesteremia and hypertriglyceridemia represent distinctly different defects in lipid metabolism. This concept is further supported by additional clinical features which have been noted by others. These include: (1) the diabetic diathesis is rare in primary hypercholesteremia and common in the combined group; (2) differences in lipid transport mechanisms are revealed by differences in lipoprotein patterns; (3) the combined group is very responsive to weight reduction and, to a lesser degree, to restriction of simple carbohydrate; and (4) there are differences in response to drug therapy. Circulation, Volume XL, July 1969 If this concept is accepted, it follows that any future epidemiologic, metabolic, or therapeutic investigation must take these differences into account. It also follows that metabolic data in patients with a normal lipid metabolism may not be applicable to patients with increased blood lipid levels because the latter have distinct metabolic defects. It is inevitable that further subclassification of these groups of patients will occur in the future. Whether these will also have clinical and therapeutic implications will require further investigation.
